ETABLISSEMENT FRANCAIS DU SANG (EFS)
🏢 View company profile →33Patents
32Active
33Granted
54Portfolio score
Filing activity: Dec 16, 2003 → May 10, 2022 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10660329B2 | Method for preserving cells, tissues or organs in hypothermia | Human Necessities | 10 | Active |
| US10188097B2 | Medical device intended for the long-term storage of a cornea, or for ex vivo experimentation on a human or animal cornea | Human Necessities | 3 | Active |
| US9743877B2 | Device for taking a sample of a body fluid and method for implementing same | Human Necessities | 3 | Active |
| US7341870B2 | Dendritic cell line | Chemistry; Metallurgy | 2 | Expired |
| US9770557B2 | Secure perfusion system | Human Necessities | 1 | Active |
| US11793865B2 | Cultured phagocyte supernatent compositions | Chemistry; Metallurgy | 1 | Active |
| US11364271B2 | Methods of treating Pseudomonas aeruginosa respiratory infections | Human Necessities | 1 | Active |
| US10653758B2 | Disease therapy using a tolerogenic pharmaceutical preparation | Chemistry; Metallurgy | 1 | Active |
| US11231427B2 | Method for determining the haemoglobin F content of an erythroid cell | Physics | 1 | Active |
| US11839630B2 | CAR-T cells targeting IL-1RAP and their use | Chemistry; Metallurgy | 0 | Active |
| US12276000B2 | Methods for predicting the risk of developing pulmonary colonization/infection by Pseudomonas aeruginosa | Chemistry; Metallurgy | 0 | Active |
| US11225684B2 | Method and device for SNP genotyping | Chemistry; Metallurgy | 0 | Active |
| US12258577B2 | Method effector cells using anti-CD127 antibodies for applications in cell therapy | Chemistry; Metallurgy | 0 | Active |
| US8859298B2 | Nanobeads covered with plasminogen as a direct support for cyclic amplification of the prion protein PrPSC | Physics | 0 | Active |
| US11903982B2 | Methods of treating pseudomonas aeruginosa respiratory infections | Human Necessities | 0 | Active |
| US11248261B2 | RhD gene allele associated with a weak D phenotype and its uses | Chemistry; Metallurgy | 0 | Active |
| US9896473B2 | Thiol compounds and the use thereof for the synthesis of modified oligonucleotides | Chemistry; Metallurgy | 0 | Active |
| US11773163B2 | Methods and pharmaceutical compositions for the prophylactic treatment of metastases | Chemistry; Metallurgy | 0 | Active |
| US11458118B2 | Methods and pharmaceutical compositions for the treatment of diseases associated with reduced CFTR function | Chemistry; Metallurgy | 0 | Active |
| US9375464B2 | HLA-G isoform for use in the treatment of a disease associated with bone resorption | Human Necessities | 0 | Active |
| US8802363B2 | Zeodration method for the preservation of blood platelets | Emerging Cross-Sectional Technologies | 0 | Active |
| US8759503B2 | Truncated CD20 protein, deltaCD20 | Chemistry; Metallurgy | 0 | Active |
| US12265084B2 | Method for analyzing the platelets of a blood sample | Physics | 0 | Active |
| US11078229B2 | Thiol compounds and the use thereof for the synthesis of modified oligonucleotides | Chemistry; Metallurgy | 0 | Active |
| US11589575B2 | Injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.